Ivera Medical Corporation v. Hospira, Inc.

801 F.3d 1336, 116 U.S.P.Q. 2d (BNA) 1400, 2015 U.S. App. LEXIS 15913, 2015 WL 5214621
CourtCourt of Appeals for the Federal Circuit
DecidedSeptember 8, 2015
Docket2014-1613, 2014-1614
StatusPublished
Cited by7 cases

This text of 801 F.3d 1336 (Ivera Medical Corporation v. Hospira, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ivera Medical Corporation v. Hospira, Inc., 801 F.3d 1336, 116 U.S.P.Q. 2d (BNA) 1400, 2015 U.S. App. LEXIS 15913, 2015 WL 5214621 (Fed. Cir. 2015).

Opinion

REYNA, Circuit Judge.

Ivera Medical Corp. (“Ivera”) sued Hos-pira, Inc. (“Hospira”) in the Southern District of California alleging infringement of U.S. Patent Nos. 7,780,794 (the '794 patent), 7,985,302 (the '302 patent), and 8,206,514 (the '514 patent). The district court granted summary judgment of invalidity, finding the asserted patent claims obvious under 35 U.S.C. § 103. Ivera appeals. For the reasons that follow, we reverse and remand.

*1338 BACKGROUND

A. The Patents-in-Suit.

The '514 patent is a continuation of '302 patent, which is a continuation of the '794 patent. All three patents share the same written description. 1 The patents explain that medical implements, such as catheters and luer ports, are common sites for transmissions of pathogens into patients. '794 patent col. 1 11. 32-35. To prevent these types of transmissions, medical staff traditionally swabbed a site before making connections to medical implements. Id. col. 1 11. 41-45. The swabs came in a small pad of cotton ’gauze soaked in a cleaning agent (e.g., isopropyl alcohol) and packed in a foil package to prevent evaporation. Id. col. 1 11. 45^17. After swabbing, the site is allowed to dry, killing any pathogens. Id. col. 111. 48-55.

In practice, these swabbing procedures were often “overlooked” or “poorly executed.” Id. col. 1 11. 56-58. To overcome this problem, the inventors provided a cleaning device that includes a cap that, when used, reliably disinfects a medical implement. For example, FIG. 6, provided below, shows a cross-sectional diagram of a cleaning device 100 that includes a cap 102. Id. col. 6 11. 19-20. Cap 102 includes threads 105 adapted to receive a medical implement, and first and second cleaning materials 107 and 108. Id. col. 6 11. 26-30 and 49-52. When the medical implement is twisted into cap 102, first cleaning material 107 compresses radially, cleansing the sides of the implement, and second cleaning material 108 compresses axially, cleansing the foremost surface of the implement. See id. col. 711. 27-33.

[[Image here]]

Central to the parties’ arguments on summary judgment are openings that permit venting of the interior of the cap. The patents describe two embodiments of these openings. First, in FIG. 6, threaded ring 106 can create “a small vent aperture or opening” relative to the inner wall of cap 102 to allow evaporation of the cleaning agent in cap 102. Id. col. 6 11. 37-43. Second, in FIG. 14 (provided below), holes 164 are formed in housing 162 of the cap. Holes 164 “can promote evaporation of the cleaning agent, particularly when the housing covers a site of a medical implement to be disinfected.” Id. col. 8 11.15-17.

*1339 [[Image here]]

The asserted claims of the patents-in-suit recite cleaning devices that include a “second opening,” “aperture,” or “means for venting” that inhibit pressure buildup and allow for evaporation. 2 For example, claim 13 of the '794 patent recites:

13. A cleaning device for a medical implement, the cleaning device comprising: a cap having a first opening to an inner cavity, an inner surface of the first opening including one or more threads adapted to receive a site of the medical implement;
a cleaning material formed of a compressible material that is at least partially secured in the inner cavity, the cleaning material containing a cleaning agent;
a second opening in the cap to allow evaporation of the cleaning agent from the inner cavity and to inhibit a buildup of pressure in the cap when the cleaning material is compressed by the site of the medical implement and a removable covering that covers the first opening and the second opening to the inner cavity prior to coupling the threads of the cap with the site of the medical implement via the first opening.

'794 patent col. 10 11. 1-17 (emphasis added).

B. The Prior Art.

1. Hoang.

U.S. Patent Application Publication No. 2007/0112333 (“Hoang”) describes a “device for antiseptically maintaining a patient fluid line access valve.” Hoang, ¶ 5. The parties focus their attention on FIG. 10b of Hoang, which is provided below. FIG. 10b shows a cap device 78 that has a lid 78a and a pad 80. Id. ¶ 43. Cap device 78 can be twisted onto a patient’s valve using its threads (not numerically referenced in FIG. 10b). Id. ¶ 44. Pad 80 can be used as a “dry” pad or a “wet” pad. Id. ¶ 43. When used as a “dry” pad, pad 80 is impregnated with an antimicrobial agent that maintains antiseptic conditions on the *1340 access portion of a valve. Id. ¶ 23. When used as a wet pad, pad 80 is impregnated with a cleaning agent and, optionally, an antimicrobial agent. Id. ¶ 27. In this latter example, pad 80 can clean the valve as cap device 78 is twisted on to the valve. Id. ¶ 44.

2. Chin-Loy.

U.S. Patent No. 5,954,957 (“Chin-Loy”) describes a cap adapted to cover blood ports or other hydraulic connection ports for medical devices such as hemodialysis machines. Chin-Loy col. 3 11. 19-23. FIG. 1 of Chin-Loy, provided below, shows a cap 10 with a first end 12 defining a female portion 16, which receives a male blood port. Id. col. 3 11. 54-57. Side wall 22 and end wall 24 together define a receptacle 34 that receives the male nipple. Id. col. 4 11. 5-7. Cap 10 can be twisted onto a blood port when the port is threaded or can “snap on” for unthreaded ports. Id. col. 4 11. 32-35, col. 4 11. 46-49. Cap 10 also includes a channel 66 defined by interior surface 28. Id. col. 5 11. 1-2. "When cap 10 is attached to a blood port, channel 66 permits “venting of the medical device through the male blood nipple while maintaining an internal condition of the medical device until time of use.” Id. col. 2 11. 41-43 and col. 5 11.12-15.

*1341 [[Image here]]

3. White.

U.S. Patent No. 5,242,425 (“White”) describes a catheter assembly that includes a distal member and a proximal member. 3 FIG. 7 of White, provided below, shows an example catheter assembly that includes a distal member 70 having a finger grip 72. White col. 711. 23-25. Distal member 70 is connected to flexible catheter tubing 18 and proximal member 82. Id. col. 7 11. 29-32. Proximal member 82 has a self-sealing septum 84 through which a needle can be inserted to introduce liquids into catheter tubing 18.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
801 F.3d 1336, 116 U.S.P.Q. 2d (BNA) 1400, 2015 U.S. App. LEXIS 15913, 2015 WL 5214621, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ivera-medical-corporation-v-hospira-inc-cafc-2015.